Id |
Subject |
Object |
Predicate |
Lexical cue |
T232 |
0-13 |
Sentence |
denotes |
3 Conclusion |
T233 |
14-166 |
Sentence |
denotes |
We synthesized 16 adenine dinucleosides which were designed as bisubstrate SAM analogs to mimic the transition state of 2′-O-methylation of the cap RNA. |
T234 |
167-415 |
Sentence |
denotes |
Both adenosines were connected by various NH or N-substituted linkers between the 2′-O-position of the adenosine representing the 5′-end nucleoside of mRNA and the 5′-position of the adenosine mimicking the SAM cofactor in the methylation reaction. |
T235 |
416-548 |
Sentence |
denotes |
None of these bisubstrate SAM analogs were found to inhibit 2′-O MTases of several flaviviruses, coronavirus or pox-virus at 200 μM. |
T236 |
549-672 |
Sentence |
denotes |
Conversely, six of them inhibited SARS-CoV nsp14 N7-MTase in micromolar range concentration and one in submicromolar range. |
T237 |
673-891 |
Sentence |
denotes |
Additionally, we also observed that these compounds barely inhibit the human RNA N7 MTase, an important feature given that the lack of antiviral specificity represents a common issue in coronavirus antiviral discovery. |
T238 |
892-1026 |
Sentence |
denotes |
Indeed, the structural homology between viral and cellular MTases often impairs the discovery of specific inhibitors for CoV N7-MTase. |
T239 |
1027-1325 |
Sentence |
denotes |
Nevertheless, our work did identify one dinucleoside (13) bearing a 4-chloro-3-nitrobenzenesulfonamide moiety in the N-linker between both adenosines, that blocks the activity of SARS-CoV nsp14 at the submicromolar concentration in the same range than sinefungin but with a significant specificity. |
T240 |
1326-1489 |
Sentence |
denotes |
Thermal shift assays and molecular modeling indicate that the inhibitory activity is likely due to the binding of 13 to both SAM and mRNA binding pockets of nsp14. |
T241 |
1490-1674 |
Sentence |
denotes |
It is quite interesting to note that all residues of SARS-CoV nsp14 involved in the binding of 13 are fully conserved in the SARS-CoV-2 nsp14 protein (Fig. S1, Supporting Information). |
T242 |
1675-1787 |
Sentence |
denotes |
Indeed, the genome sequence of SARS-CoV-2 nsp14 exhibits about 95% sequence similarity with SARS-CoV nsp14 [38]. |
T243 |
1788-1931 |
Sentence |
denotes |
The lead compound 13 and the most potent derivatives will serve as starting building blocks for the development of SARS-CoV-2 nsp14 inhibitors. |